Latest news
Personalis, Inc. Q2 2026: Revenue $22.36M, EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 20:23:17 GMTPersonalis Q2 revenue rises 30%, beats estimates on expanded Medicare coverage - TradingViewTradingView · Tue, 04 Aug 2026 20:13:40 GMTPSNL: Q2 2026 revenue up 30% YoY, merger with Tempus announced, net loss widened on higher costs - TradingViewTradingView · Tue, 04 Aug 2026 20:12:01 GMTPSNL: Clinical revenue soared 442% year-over-year, with strong growth in test volume and expanded Medicare coverage - TradingViewTradingView · Tue, 04 Aug 2026 20:09:24 GMTAre BOW, UTZ, PSNL Obtaining Fair Deals for their Shareholders? - TradingViewTradingView · Tue, 04 Aug 2026 16:52:00 GMTPSNL Q2'26 Earnings: revenue estimate is 16.69M USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:06 GMTPersonalis, Inc. Actuals & Estimates (NASDAQ:PSNL) - TradingViewTradingView · Sat, 01 Aug 2026 05:07:57 GMTTEM: Q2 revenue up 22% YoY, with major deals, FDA wins, and Personalis acquisition fueling growth - TradingViewTradingView · Thu, 30 Jul 2026 22:05:10 GMT